Feb 16, 2016
Trials moving ahead for treatment of most aggressive form of brain cancer
Posted by Karen Hurst in categories: biotech/medical, neuroscience
Wonderful news for Glioblastoma patients; 2nd clinical trails is underway for the two drug combination that researchers are using to disrupt the cellular process cancer cells use to hide from the immune system and allow the immune system to recognize and attack the cancer.
The UNM Comprehensive Cancer Center has started phase 2 clinical trials, targeting glioblastoma patients.
Glioblastoma is a particularly aggressive type of brain cancer. Only about one fifth of adults diagnosed with it survive two years or more after their diagnosis, UNM researchers said.
Continue reading “Trials moving ahead for treatment of most aggressive form of brain cancer” »